Delivery Order SPE2DB25D7067-SPE2DB25FSVLD
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order for Copaxone 40 mg/ml syringes valued at $1,041.36 by the Defense Logistics Agency's Medical Supply Chain on August 19, 2025. This competitive, firm fixed-price contract has an ultimate completion date of August 20, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which is valued at $999,999,999 and extends through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $2,989.35 to AmerisourceBergen Drug Corp for Copaxone 40 mg/ml syringes, with completion scheduled for July 22, 2025. This non-set-aside, competitively awarded contract reflects a firm fixed price arrangement typical of pharmaceutical procurement through the federal medical supply chain. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The $1,583.28 firm fixed-price award is for the supply of Copaxone 40 mg/mL syringes, a specialty medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of COPAXONE 40 MG/ML SYRINGEML, a pharmaceutical product. The contract has a ceiling value of $4,749.84 and a completion date of July 29, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the government to efficiently procure a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $4,215.36, is for the supply of COPAXONE 40 MG/ML syringes, a specialty medication used to treat multiple sclerosis. The contract has a fixed-price delivery order structure and an ultimate completion date of August 26, 2024. AmerisourceBergen holds a larger $999,999,999...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,328.78, is for the delivery of COPAXONE 40 MG/ML syringes, a specialty medication. The contract has an ultimate completion date of June 17, 2024 and is a Firm Fixed Price delivery order. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of COPAXONE 40 MG/ML SYRINGEML, with a ceiling value of $1,092.00 and a period of performance through May 14, 2025. This delivery order is not set aside and is priced on a firm fixed-price basis. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a for-profit pharmaceutical sourcing and distribution company. The $2,010.87 order is for the drug Copaxone 40 mg/ml in syringes, with a period of performance through March 25, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, is the prime contractor. This order is issued under an indefinite delivery contract (IDC) awarded by DLA to...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $3,245.16 contract is for the delivery of COPAXONE 40 MG/ML syringes to a location in Conshohocken, Pennsylvania. The contract has a completion date of February 9, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This award is...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) for the delivery of COPAXONE 40 MG/ML SYRINGE ML pharmaceutical products. The firm fixed price delivery order has a potential value of $3,562.48 and a completion date of February 13, 2024. This award is not associated with any set-aside program. Amerisourcebergen Drug Corp serves as the prime contractor, providing pharmaceutical and medical...
- SPE2DB25D7067Indefinite Delivery Contract
- SPE2DB25D7067-SPE2DB25FSVLDDelivery Order
The Defense Logistics Agency awarded a $4,368 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Copaxone 40 mg/ml syringes. The contract, awarded on July 29, 2025, with an ultimate completion date of July 30, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. This award was competitively awarded with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order falls under AmerisourceBergen's prime Indefinite Delivery Contract (SPE2DX) valued at $999,999,999 and running through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for the DLA Troop Support Medical. The contract enables supply of a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, and medical devices. AmerisourceBergen's federal contract portfolio demonstrates its capability to fulfill diverse medical supply requirements across multiple therapeutic domains for customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 7/29/25 |